Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
- Conditions
- Kidney Transplant Recipients
- Interventions
- Biological: Varivax®
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2017-02-16
- Target Recruit Count
- 7
- Registration Number
- NCT00005009
- Locations
- 🇺🇸
University of Michigan - Vaccine and Treatment Evaluation Unit (VTEU), Ann Arbor, Michigan, United States
🇺🇸Boston Children's Hospital - Vaccine and Treatment Evaluation Unit (VTEU), Boston, Massachusetts, United States
🇺🇸University of Alabama at Birmingham - Vaccine and Treatment Evaluation Unit (VTEU), Birmingham, Alabama, United States
Treatment of Chronic Cryptosporidiosis in AIDS Patients
- Conditions
- CryptosporidiosisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-12-14
- Target Recruit Count
- 16
- Registration Number
- NCT00001128
- Locations
- 🇺🇸
Pablo C. Okhuysen, Houston, Texas, United States
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
- Conditions
- HIV Infections
- Locations
- 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States
Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples
- Conditions
- HIV Infections
- Interventions
- Behavioral: Group counseling intervention
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-11-06
- Target Recruit Count
- 90
- Registration Number
- NCT00000928
Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 370
- Registration Number
- NCT00000816
- Locations
- 🇺🇸
Rush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States
🇺🇸Beth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston, Massachusetts, United States
A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 400
- Registration Number
- NCT00000969
- Locations
- 🇺🇸
Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States
🇺🇸Hill Health Corp, New Haven, Connecticut, United States
🇺🇸Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 130
- Registration Number
- NCT00000779
- Locations
- 🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸Santa Clara Valley Med. Ctr., San Jose, California, United States
🇺🇸NY Univ. HIV/AIDS CRS, New York, New York, United States
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 15
- Registration Number
- NCT00000742
- Locations
- 🇺🇸
Univ. of Rochester ACTG CRS, Rochester, New York, United States
🇺🇸Washington U CRS, Saint Louis, Missouri, United States
🇺🇸USC CRS, Los Angeles, California, United States
A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 420
- Registration Number
- NCT00000871
- Locations
- 🇺🇸
Fenway Community Health Center HIVNET, Boston, Massachusetts, United States
🇺🇸Univ. of Pennsylvania HIVNET, Philadelphia, Pennsylvania, United States
🇺🇸Univ. of Illinois at Chicago HIVNET, Chicago, Illinois, United States
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 60
- Registration Number
- NCT00000754
- Locations
- 🇺🇸
Alabama Therapeutics CRS, Birmingham, Alabama, United States
🇺🇸Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸Ucsd, Avrc Crs, La Jolla, California, United States